Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review
Background Pricing and reimbursement (P&R) systems do not normally use public investments in research and development (R&D) as criteria when negotiating the prices and reimbursement of health technologies. Objective The objective was to find mechanisms that consider public investment in R&D when negotiating P&R or obtaining a fair return on this public investment Methods We…












